HQL insider transactions
abrdn Life Sciences Investors Shares of Beneficial Interest (HQL) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for HQL
- SEC Form 3 filed by new insider Reilly Heather Carter3 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Director Pittard Christian bought $133,755 worth of shares (7,923 units at $16.88) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $687,094 worth of shares (48,612 units at $14.13) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $906,075 worth of shares (64,536 units at $14.04) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $38,235 worth of shares (2,726 units at $14.03) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $215,856 worth of shares (15,116 units at $14.28) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $197,725 worth of shares (14,083 units at $14.04) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $329,512 worth of shares (23,723 units at $13.89) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $5,532 worth of shares (400 units at $13.83) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $150,690 worth of shares (10,710 units at $14.07) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- SEC Form 3 filed by new insider Dietrick Joseph Francis3 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $145,135 worth of shares (11,419 units at $12.71) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $286,646 worth of shares (23,729 units at $12.08) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $16,188 worth of shares (1,330 units at $12.17) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $152,014 worth of shares (12,689 units at $11.98) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $16,652 worth of shares (1,366 units at $12.19) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $107,716 worth of shares (9,144 units at $11.78) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $20,264 worth of shares (1,700 units at $11.92) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $179,718 worth of shares (15,400 units at $11.67) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $335,938 worth of shares (30,156 units at $11.14) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $205,932 worth of shares (17,210 units at $11.97) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $576,754 worth of shares (46,723 units at $12.34) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $611,677 worth of shares (48,623 units at $12.58) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $474,961 worth of shares (36,524 units at $13.00) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $30,766 worth of shares (2,329 units at $13.21) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- SEC Form 3 filed by new insider Hepp Robert W.3 - abrdn Life Sciences Investors (0000884121) (Issuer)
- SEC Form 3 filed by new insider Gebauer Katie Lynn3 - abrdn Life Sciences Investors (0000884121) (Issuer)
- SEC Form 3 filed by new insider Hasson Heather3 - abrdn Life Sciences Investors (0000884121) (Issuer)
- SEC Form 3 filed by new insider Marsico Michael3 - abrdn Life Sciences Investors (0000884121) (Issuer)
- SEC Form 3 filed by new insider Taggart Michael3 - abrdn Life Sciences Investors (0000884121) (Issuer)
- SEC Form 3 filed by new insider Kim Andrew Wonil3 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $2,724 worth of shares (200 units at $13.62) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $1,388 worth of shares (100 units at $13.88) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $502,370 worth of shares (36,536 units at $13.75) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $871,709 worth of shares (62,743 units at $13.89) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $83,013 worth of shares (5,911 units at $14.04) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $525,274 worth of shares (36,978 units at $14.21) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. sold $164,837 worth of shares (11,674 units at $14.12) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- SEC Form 3 filed by new insider Silue Kolotioloma3 - abrdn Life Sciences Investors (0000884121) (Issuer)
- SEC Form 3 filed by new insider Wilson Ashton3 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Director Maher Bill bought $9,990 worth of shares (650 units at $15.37) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Director Dimartino Rose bought $15,530 worth of shares (1,000 units at $15.53) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. bought $1,407 worth of shares (100 units at $14.07) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. bought $194,473 worth of shares (13,812 units at $14.08) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- SEC Form 3 filed by new insider Taggart Michael3 - abrdn Life Sciences Investors (0000884121) (Issuer)
- New insider Nichols Rebecca Suzanne claimed no ownership of stock in the company (SEC Form 3)3 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. bought $150,326 worth of shares (10,867 units at $13.83) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Large owner Saba Capital Management, L.P. bought $161,098 worth of shares (11,743 units at $13.72) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Saba Capital Management, L.P. bought $184,081 worth of shares (13,361 units at $13.78) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Saba Capital Management, L.P. bought $809,222 worth of shares (59,440 units at $13.61) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Saba Capital Management, L.P. bought $283,994 worth of shares (21,369 units at $13.29) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Saba Capital Management, L.P. bought $623,176 worth of shares (47,416 units at $13.14) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Saba Capital Management, L.P. bought $17,590 worth of shares (1,303 units at $13.50) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Saba Capital Management, L.P. bought $493,173 worth of shares (34,755 units at $14.19) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Saba Capital Management, L.P. bought $801,967 worth of shares (57,862 units at $13.86) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Saba Capital Management, L.P. bought $390,256 worth of shares (28,359 units at $13.76) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Saba Capital Management, L.P. bought $836,126 worth of shares (60,874 units at $13.74) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Saba Capital Management, L.P. bought $356,929 worth of shares (26,526 units at $13.46) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Saba Capital Management, L.P. bought $217,603 worth of shares (16,573 units at $13.13) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)
- Saba Capital Management, L.P. bought $1,563,952 worth of shares (120,304 units at $13.00) (SEC Form 4)4 - abrdn Life Sciences Investors (0000884121) (Issuer)